A Virtual Screening Approach for Thymidine Monophosphate Kinase Inhibitors as Antitubercular Agents Based on Docking and Pharmacophore Models

B. Gopalakrishnan; V. Aparna; J. Jeevan; M. Ravi; G. R. Desiraju

doi:10.1021/ci050064z

journal article May 27, 2005

A Virtual Screening Approach for Thymidine Monophosphate Kinase Inhibitors as Antitubercular Agents Based on Docking and Pharmacophore Models

B. Gopalakrishnan V. Aparna J. Jeevan M. Ravi G. R. Desiraju

Journal of Chemical Information and Modeling Vol. 45 No. 4 pp. 1101-1108 · American Chemical Society (ACS)

View at Publisher Save 10.1021/ci050064z

Topics

No keywords indexed for this article. Browse by subject →

References

35

[1]

Bajorath J Nat. Rev. Drug Discovery (2002) 10.1038/nrd941

[2]

Lyne P. D Drug Discovery Today (2002)

[3]

Xue L. J. Chem. Inf. Comput. Sci. (2004)

[4]

Sirois S. J. Chem. Inf. Comput. Sci. (2004) 10.1021/ci034270n

[5]

Debnath A. K J. Med. Chem. (2002) 10.1021/jm010360c

[6]

Srinivasan J. J. Med. Chem. (2002) 10.1021/jm010494q

[7]

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al.

Advanced Drug Delivery Reviews 1997 10.1016/s0169-409x(96)00423-1

[8]

Schneider G. Drug Discovery Today (2002) 10.1016/s1359-6446(01)02091-8

[9]

Krovat E. M. J. Chem. Inf. Comput. Sci. (2004) 10.1021/ci0342728

[10]

Verdonk M. L. J. Chem. Inf. Comput. Sci. (2004) 10.1021/ci034289q

[11]

Taylor R. D. J. Comput.-Aided Mol. Des. (2002) 10.1023/a:1020155510718

[12]

Grüneberg S. J. Med. Chem. (2002) 10.1021/jm011112j

[13]

Steindl T. J. Chem. Inf. Comput. Sci. (2004) 10.1021/ci049844i

[14]

Stokstad E. Science (2000) 10.1126/science.287.5462.2391a

[15]

Dye C. Science (2002)

[16]

Haouz A. J. Biol. Chem. (2003) 10.1074/jbc.m209630200

[17]

Lavie A. Proc. Natl. Acad. Sci. U.S.A. (1998) 10.1073/pnas.95.24.14045

[18]

Ostermann N. Biochemistry (2003) 10.1021/bi027302t

[19]

Vanheusden V. J. Med. Chem. (2003) 10.1021/jm021108n

[20]

Pochet S. ChemBioChem (2003) 10.1002/cbic.200300608

[21]

Sierra L. D. L. J. Mol. Biol. (2001)

[22]

Vanheusden V. Bioorg. Med. Chem. Lett. (2002) 10.1016/s0960-894x(02)00551-6

[23]

Vanheusden V. Bioorg. Med. Chem. Lett. (2003) 10.1016/s0960-894x(03)00643-7

[24]

Cerius

[25]

Insight II (1997)

[26]

GOLD

[27]

Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Gareth Jones, Peter Willett, Robert C Glen et al.

Journal of Molecular Biology 1997 10.1006/jmbi.1996.0897

[28]

Catalyst

[29]

Smellie A. J. Comput. Chem. (1995) 10.1002/jcc.540160205

[30]

Güner O. F. (2000)

[31]

Lommerse J. P. M. J. Am. Chem. Soc. (1996)

[32]

Auffinger P. Proc. Natl. Acad. Sci. U.S.A. (2004) 10.1073/pnas.0407607101

[33]

Steinrauf L. K. J. Biol. Chem. (1993)

[34]

Hydrogen Bonding in Biological Structures

George A. Jeffrey, Wolfram Saenger

1991 10.1007/978-3-642-85135-3

[35]

Sarkhel S. Proteins (2004) 10.1002/prot.10567

Cited By

62

Inhibitory effect of synthetic aromatic heterocycle thiosemicarbazone derivatives on mushroom tyrosinase: Insights from fluorescence, 1 H NMR titration and molecular docking studies

Juan Xie, Huanhuan Dong · 2016

Food Chemistry

The Bright Future of Unconventional σ/π‐Hole Interactions

Antonio Bauzá, Tiddo J. Mooibroek · 2015

ChemPhysChem

Metrics

62

Citations

35

References

Details

Published: May 27, 2005
Vol/Issue: 45(4)
Pages: 1101-1108

Authors

B

B. Gopalakrishnan